Opdahl S

No ORCID on file · 4 papers in corpus · active 2023-2026
2026
Cancer Incidence in Women After Medically Assisted Reproduction.
JAMA network open ·doi:10.1001/jamanetworkopen.2026.1332

ImportanceHigh-quality evidence on cancer occurrence for women who have used medically assisted reproduction (MAR) is required to guide care.ObjectiveTo compare cancer incidence in MAR-exposed women with the general population of women.Desi…

2023
Maternal Risk of Cardiovascular Disease After Use of Assisted Reproductive Technologies.
JAMA cardiology ·doi:10.1001/jamacardio.2023.2324

ImportanceThe use of assisted reproductive technologies (ARTs) is steadily increasing worldwide. The outcomes associated with treatment for an individual's long-term health, including risk of cardiovascular disease (CVD), remain largely unk…

2023
Risk of ovarian cancer in women who give birth after assisted reproductive technology (ART)-a registry-based Nordic cohort study with follow-up from first pregnancy.
British journal of cancer ·doi:10.1038/s41416-022-02097-7

BackgroundThere is concern that assisted reproductive technology (ART) may increase ovarian cancer risk, but previous studies are inconclusive. We compared ovarian cancer risk for women who gave birth after ART vs natural conception.Methods…

2023
Risk of stillbirth and neonatal death in singletons born after fresh and frozen embryo transfer: cohort study from the Committee of Nordic Assisted Reproduction Technology and Safety.
Fertility and sterility ·doi:10.1016/j.fertnstert.2022.10.020

ObjectivesTo investigate whether risks of stillbirth and neonatal death differ after fresh embryo transfers (fresh-ETs) and frozen embryo transfers (frozen-ETs) compared with singletons conceived without medical assistance.DesignA populatio…